Jones Financial Companies
NNVC icon

Jones Financial Companies’s NanoViricides NNVC Stock Holding History

Jones Financial Companies’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.72K Hold
3,000
– – ﹤0.01% 4062
2025
Q4 		$3.39K Buy
+3,000
New +$4.21K ﹤0.01% 3659

Other funds holding NNVC

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $91.3M AUM 21.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jones Financial Companies's NNVC Position: Q1 2026 in Review

Jones Financial Companies held its NanoViricides (NNVC) position steady in Q1 2026 at 3,000 shares worth $2.72K. The position accounts for ﹤0.01% of the portfolio, ranked #4062.

Jones Financial Companies first reported a position in NNVC in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.39K in Q4 2025. 48 funds tracked by Wall St. Rank hold NNVC as of Q1 2026.

  • Jones Financial Companies held 3,000 shares of NanoViricides worth $2.72K as of Q1 2026.
  • Jones Financial Companies left its NanoViricides share count unchanged in Q1 2026.
  • NanoViricides made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4062 holding.
  • Jones Financial Companies first reported a position in NanoViricides in Q4 2025 and has held it in 2 quarters since.
  • Jones Financial Companies's NanoViricides position peaked at $3.39K in Q4 2025.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.